Remove 2026 Remove Chemotherapy Remove Immunization
article thumbnail

Future of Bispecific Antibody: Exploring the Rise in Approvals

Roots Analysis

They are designed to recognize and bind to two specific molecules, such as a tumor cell and an immune cell, or two different parts of the same molecule. Bispecific antibodies are a type of antibody that can bind to two different targets at the same time. during the period 2023-2035.

article thumbnail

Jiashu Xie, PhD

Blog: Ask a Student Pharmacist

Particularly, we devote a large portion of our research to identifying novel compounds that impact cellular uptake or inhibit drug efflux - the most common mechanism underlying acquired drug resistance in cancer, pinpointing the transporters or targets involved in these processes, and evaluating regimens to produce desirable anti-cancer responses.